Effect of Caudal and Penile Block on Hypospadias Repair Complications
Launched by BAYLOR COLLEGE OF MEDICINE · Jul 28, 2016
Trial Information
Current as of June 28, 2025
Completed
Keywords
ClinConnect Summary
Hypospadias is a one of the most common genitourinary (GU) malformations, seen in approximately 1 of 250 male live births, characterized by proximal location of the urethral meatus, dorsal hooded foreskin with incomplete ventral fusion, and ventral curvature of the penis. Hypospadias repair includes several standard steps including urethroplasty, mobilization of adjacent flaps for urethroplasty coverage, rotation of penile skin flaps and circumcision. In order for the surgeon to operate in a clean and relatively bloodless field, tourniquets and local epinephrine injection have been used. In...
Gender
MALE
Eligibility criteria
- Inclusion criteria:
- • Age 4 months to 4 years
- • ASA score I and II
- • Primary hypospadias repair in one stage including distal, midshaft, and proximal repairs
- Exclusion criteria:
- • Age \<4 months or \>4 years
- • ASA score \>II
- • Genetic syndromes
- • Previous hypospadias operations
- • Staged hypospadias repair operations
- • Spinal dysraphism or other contraindications to caudal block
- • Infection at the block site
- • Refusal of consent by the parents
- • Unwillingness of the anesthesiologist or surgeon to participate
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Nicolette K Janzen, MD
Principal Investigator
Texas Children's Hospital/Baylor College of Medicine
Kara Toman, MPH
Study Director
Texas Children's Hospital/Baylor College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials